image
Fate Therapeutics, Inc. FATE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.02
-2.88 %
$ 230 M
Market Cap
-1.23
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -34.03% 36.90% 38.22%
Annual Report FY 10-K 2022-12-31 72.44% -23.63% -42.12%
Annual Report FY 10-K 2021-12-31 77.66% -21.14% -69.41%
Annual Report FY 10-K 2020-12-31 194.33% -74.29% -27.16%
Annual Report FY 10-K 2019-12-31 125.32% -46.71% -50.13%
Annual Report FY 10-K 2018-12-31 15.44% -55.05% -59.27%
Annual Report FY 10-K 2017-12-31 -6.72% -28.36% -31.79%
Annual Report FY 10-K 2016-12-31 81.08% -11.57% -15.05%
Annual Report FY 10-K 2015-12-31 0.00% -15.88% -11.56%
Annual Report FY 10-K 2014-12-31 0.00% -23.88% -40.90%
Annual Report FY 10-K 2013-12-31 -63.63% -46.74% -30.38%
Annual Report FY 10-K 2012-12-31 128.21% -6.05% -1.99%
Annual Report FY 10-K 2011-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 58.13% -5.55% -2.14%
Quarterly Report Q2 8-K 2024-06-30 625.83% 27.16% 27.94%
Quarterly Report Q1 8-K 2024-03-31 -96.74% -423.49% -78.61%
Quarterly Report Q4 8-K 2023-12-31 -96.22% 8.66% 25.37%
Quarterly Report Q3 8-K 2023-09-30 -87.02% 44.05% 40.64%
Quarterly Report Q2 8-K 2023-06-30 -94.97% 30.68% 24.72%
Quarterly Report Q1 8-K 2023-03-31 220.30% 83.89% 61.60%
Quarterly Report Q4 8-K 2022-12-31 159.89% 29.60% 7.15%
Quarterly Report Q3 8-K 2022-09-30 5.31% -86.42% -58.16%
Quarterly Report Q2 8-K 2022-06-30 38.30% -38.04% -77.66%
Quarterly Report Q1 8-K 2022-03-31 65.27% -26.22% -61.15%
Quarterly Report Q4 8-K 2021-12-31 7.37% -29.20% -107.74%
Quarterly Report Q3 8-K 2021-09-30 88.21% 26.20% -73.48%
Quarterly Report Q2 8-K 2021-06-30 145.42% -96.40% -62.95%
Quarterly Report Q1 8-K 2021-03-31 343.02% -34.51% -33.97%
Quarterly Report Q4 8-K 2020-12-31 467.31% -87.66% -14.86%
Quarterly Report Q3 8-K 2020-09-30 211.16% -120.54% -16.11%
Quarterly Report Q2 8-K 2020-06-30 94.00% -19.57% -19.20%
Quarterly Report Q1 8-K 2020-03-31 -4.45% -69.64% -68.70%
Quarterly Report Q4 8-K 2019-12-31 68.69% -76.59% -73.69%
Quarterly Report Q3 8-K 2019-09-30 136.74% -58.56% -62.47%
Quarterly Report Q2 8-K 2019-06-30 174.29% -19.46% -22.85%
Quarterly Report Q1 8-K 2019-03-31 156.53% -39.79% -45.48%
Quarterly Report Q4 8-K 2018-12-31 61.73% -28.25% -36.73%
Quarterly Report Q3 8-K 2018-09-30 0.00% -57.08% -61.43%
Quarterly Report Q2 8-K 2018-06-30 0.10% -103.77% -104.86%
Quarterly Report Q1 8-K 2018-03-31 -0.10% -39.59% -40.95%
Quarterly Report Q4 8-K 2017-12-31 0.00% -57.39% -59.97%
Quarterly Report Q3 8-K 2017-09-30 0.00% -22.28% -23.26%
Quarterly Report Q2 8-K 2017-06-30 -0.10% -14.71% -19.57%
Quarterly Report Q1 8-K 2017-03-31 -22.31% -20.88% -25.96%
Quarterly Report Q4 8-K 2016-12-31 -4.55% -6.63% -10.73%
Quarterly Report Q3 8-K 2016-09-30 0.00% -26.88% -32.57%
Quarterly Report Q2 8-K 2016-06-30 212.16% -8.09% -10.89%
Quarterly Report Q1 8-K 2016-03-31 0.00% -6.29% -8.08%
Quarterly Report Q4 8-K 2015-12-31 0.00% -19.46% -16.30%
Quarterly Report Q3 8-K 2015-09-30 0.00% -4.29% -5.75%
Quarterly Report Q2 8-K 2015-06-30 0.00% -28.22% -19.50%
Quarterly Report Q1 8-K 2015-03-31 0.00% -12.91% -5.58%
Quarterly Report Q4 8-K 2014-12-31 100.00% -8.61% -21.24%
Quarterly Report Q3 8-K 2014-09-30 0.00% -8.73% -16.24%
Quarterly Report Q2 8-K 2014-06-30 0.00% -9.63% -41.49%
Quarterly Report Q1 8-K 2014-03-31 0.00% -96.73% -106.70%
Quarterly Report Q4 8-K 2013-12-31 -151.01% -38.12% -21.22%
Quarterly Report Q3 8-K 2013-09-30 -60.42% -47.65% -41.04%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2012-09-30 0.00% 0.00% 0.00%